Drug Shortage Report for LIDOCAINE HYDROCHLORIDE INJECTION USP

Last updated on 2025-05-02 History
Report ID 251897
Drug Identification Number 02421992
Brand name LIDOCAINE HYDROCHLORIDE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE
Strength(s) 20MG
Dosage form(s) SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2025-03-05
Actual start date
Estimated end date 2025-04-30
Actual end date 2025-04-30
Shortage status Resolved
Updated date 2025-05-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-05-02 French Compare
v8 2025-05-02 English Compare
v7 2025-04-25 French Compare
v6 2025-04-25 English Compare
v5 2025-04-01 French Compare
v4 2025-04-01 English Compare
v3 2025-03-06 English Compare
v2 2025-03-04 French Compare
v1 2025-03-04 English Compare

Showing 1 to 9 of 9